Dr. Jayaprakash Appajigol: Experienced Doctor & Specialist at KLE Hospital

About Doctor

Dr. Jayaprakash Appajigol is a renowned Consultant Physician specializing in Internal Medicine, with a wealth of experience in critical care units. He has worked at reputable institutions like Wockhardt Hospital and OPEC/Apollo Hospital, honing his expertise in diagnosing and treating a range of medical conditions. Dr. Appajigol is a multilingual practitioner, fluent in Kannada, English, Hindi, and Marathi, which enables effective communication with diverse patients. His stellar achievements in the field include being an invited participant at the prestigious 11th Cambridge Diabetes Seminar and receiving the International Diabetes Federation Grantee accolade. Dr. Appajigol has contributed significantly to medical research, with publications in esteemed journals focusing on diabetes prevalence, coronary syndromes, hypertension, gestational diabetes, and more. With memberships in various medical associations and expertise in managing conditions like multi-organ dysfunction, sepsis, dengue, chest pain, cough, and fever, Dr. Appajigol is a trusted healthcare provider dedicated to providing the highest quality of care to his patients. His commitment to ongoing research and academic pursuits ensures that he stays at the forefront of medical advancements, offering evidence-based treatments to those under his care at KLES Dr. Prabhakar Kore Hospital & MRC, Belagavi. Trust Dr. Appajigol with your health for expert medical guidance and compassionate care.

Past Experiences

Worked in Intensive Care Unit of Wockhardt Hospital, Bangalore.
Worked as consultant Physician in OPEC/Apollo Hospital, Raichur, Karnataka.

Expertise

Severe Infections
Septic shock
Multi Organ Dysfunctions

Conditions Treated

Infections
Respiratory Diseases
Diabetes
Blood pressure
Thyroid diseases
Heart diseases
Liver diseases
Kidney diseases
Brain diseases

Procedures

ECG
Pleural tapping
Lumbar puncture
Ascitic tapping

Memberships

Association of Physicians of India (API-National)
RSSDI

Publications

Jayaprakash Appajigol, Manjunath Somannavar, Ramesh Araganji. Feasibility of Oral Glucose Tolerance Test as a Diagnostic Tool for Diabetes Prevalence Study in a Rural Community. Recent Research in Science and Technology. 2011; 3(9): 53-56.
Jayaprakash Appajigol, Srivivasmurthy A. G. Qualitative assay of C- reactive proteins in acute coronary syndromes. International Multidisciplinary Research Journal 2012; 2(11): 05-08.
V Channaraya, R K Marya, M Somasundaram, Debashish Mitra, K D Tibrewala, BRIGHT investigators (Jayaprakash Appajigol). Efficacy and tolerability of a Beta-1 selective Beta blocker, bisoprolol, as a first-line antihypertensive in Indian patients diagnosed with essential hypertension (BRIGHT): an open-label, multicentric observational study. BMJ Open 2012;2.
Kajagar B.M, Mahishale. V, Jayaprakash Appajigol, Halabhavi S. N, Hazare S. Tuberculosis of liver in a patient with AIDS- A case report. Lifeline, Journal of KLE’s Dr. Prabhakar Kore Hospital and MRC Jan. 2013;24: 35-36.
Somannavar MS, Jayaprakash Appajigol. Knowledge, Attitudes, and Practices of Public Sector Primary Health Care Physicians of Rural North Karnataka towards obesity management. J Family Medicine and Primary Care 2014;3:400-3.
Jayaprakash Appajigol, Srinivas B. Knowledge and Practices of Rural Family Physicians and Obstetricians towards Gestational Diabetes Mellitus. International Journal of Community Medicine and Public Health 2015; 2: 153-5.
Jayaprakash Appajigol, Manjunath Somannavar, Ramesh Araganji. Performance of diabetes risk scores with or without point of care blood glucose estimation. Journal of the scientific society. 2015;42:24-6.
Jayaprakash Appajigol, Manjunath Somannavar, Ramesh Araganji. Prevalence of type 2 diabetes and pre-diabetes among a rural community of North Karnataka. Biomedicine. 2016; 3(36): 30-35.
Praveen Raj, RP. Garg, AK Kustagi, Dinesh Agarwal. Jayaprakash Appajigol et al. A cross-sectional, multi-centric, epidemiological study of diabetic neuropathy and associated co-morbidities in type 2 diabetic patients in India. British Journal of Medical and Health Research. 2016;3: 23-36.
Santosh Shukla, Ganachari MS, Jayaprakash Appajigol, Geetanjali Salimath, Saurabh Gaur and Vaneeta Dhyani. Efficacy and Safety of Atorvastatin in Dyslipidemic Patients at Tertiary Care Hospital. Biochemistry & Pharmacology. 2018;7(3):256.
Abhishek T.G, Arathi Darshan, Jayaprakash Appajigol, Naveen Angadi, Dr. Vijayalakshmi Chikkamath. Association between carotid intima media thickness and metabolic syndrome. International Journal of Advances in Medicine. 2018 Dec;5(6):1503-1509.
Vijayalakshmi Chikkamath, Arathi Darshan, Jayaprakash Appajigol, Naveen Angadi, Abhishek T.G. Fibrinogen Levels In Type II Diabetes Mellitus Patients With Microvascular Complications. International Journal of Advances in Medicine. 2018 Dec;5(6):1428-1431.
Modi Ranjan, M.R. Prasad, Jayaprakash Appajigol. Important coronary anomaly that may be missed by many cardiac interventionists! IHJ Cardiovasc Case Rep.2018;1-2.
Jayaprakash Appajigol. Present Scenario of Adult Hypertension: Family Physician Perspective. Journal of the scientific society. 2018;45:51-2.
Jayaprakash Appajigol. Preoperative management of hypertension. Journal of the scientific society. 2018;45:110.
Jayaprakash Appajigol, Manjunath Somannavar, Ramesh Araganji. Assessment of knowledge, attitude, and practices of medical officers in primary health centers regarding type 2 diabetes mellitus. Journal of Medicine. 2019;20:63-67
Jean-Louis Vincent, Bruno Francois, Igor Zabolotskikh et al, SCARLET Trial Group (Jayaprakash Appajigol). Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy-The SCARLET Randomized Clinical Trial. JAMA 2019; E9-E10.
Jayaprakash Appajigol. Study of Practices Regarding Dengue Fever Among Adult Population Visiting A Tertiary Care Hospital. Life Line, Journal of KLEs Dr. Prabhakar Kore Hospital and Research.2019;37:21-23.
Jayaprakash Appajigol. Audio-visual consent process in clinical research. J Sci Soc 2018;45:111-2.
Adarshkumar Bellad, Rajiv Raina, Sanjeev Asotra, Malay Sarkar, Ashok Sharma, Jayaprakash Appajigol. Endothelial Function and Subclinical Atherosclerosis in Patients of Chronic Obstructive Pulmonary Disease. Journal of the Bahrain Medical Society.2019;31(4):1-6.
Jayaprakash Appajigol, Manjunath Somannavar, Ramesh Araganji. Sensitivity and specificity of waist circumference as a screening tool for assessment of obesity in rural population. APIK J Int Med 2020;8:11-4.
Dr. Aastha Poddar, Dr. Abhishek Gogate, Dr. Anusha S Kumbar, Dr. Kurt Sydney Francis Cordeiro, Dr. Jayaprakash Appajigol, Dr. Shivalingappa B. Javali. Factors associated with case fatality in COVID-19. J Sci Soc 2020;47:79?84.
Dr. Aastha Poddar, Dr. Abhishek Gogate, Dr. Anusha S Kumbar, Dr. Kurt Sydney Francis Cordeiro Knowledge, attitude and practice regarding COVID-19 among general population using internet. Medical Journal of Dr. D.Y. Patil Vidyapeeth. 2020. In press.
Madhav Prabhu, Harpreet Kour1, Shivani Charuhas Bhagwat, Akash Ramaswamy, Arathi Darshan, Jayaprakash Appajigol. Convalescent plasma therapy in the management of COVID?19 patients and its effect on morbidity and mortality. BLDE Univ J Health Sci. 2023;8(1):142.
Kumar A, Darshan A, Prabhu M, Appajigol Jayaprakash, Patil B, Gautam S. Clinical characteristics and risk factors for COVID?19?related adverse outcomes in patients with type 2 diabetes mellitus. J Clin Sci Res 2023;12(Suppl 1):5-10.
Rishabh Soni, Ambrish Nerlikar, Jayaprakash Appajigol. Clinical profile and patterns of antimicrobial resistance in ventilator-associated pneumonia patients. Afr.J.Bio.Sc. 6(13) (2024) 3819-3829.

Dr. JayaprakashAppajigol